These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7482393)

  • 1. [Determination of drug posology in pediatrics].
    Autret E; Vasmant D
    Therapie; 1995; 50(4):381-6. PubMed ID: 7482393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of medicines for children in Europe: ethical implications.
    Saint Raymond A; Brasseur D
    Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are children getting the right drugs?].
    Bratlid D
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems in paediatric prescribing.
    Catzel P
    Practitioner; 1976 Sep; 217(1299):396-402. PubMed ID: 981131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate oral formulations and information in paediatric trials.
    Pandit S; Shah U; Kirby DJ; Nunn T; Tuleu C
    Arch Dis Child; 2010 Sep; 95(9):754-6. PubMed ID: 20605870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Developing a dose-administration schedule for drug therapy in childhood].
    Richter O; Reinhardt D; Stutzinger W
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):63-5. PubMed ID: 6843558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in paediatric pharmacokinetics.
    Knibbe CA; Krekels EH; Danhof M
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):1-8. PubMed ID: 21117982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?
    Baber NS
    Br J Clin Pharmacol; 2005 Jun; 59(6):660-2. PubMed ID: 15948928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prescriptions and children].
    Autret-Leca E; Bensouda-Grimaldi L; Le Guellec C; Jonville-Béra AP
    Arch Pediatr; 2006 Feb; 13(2):181-5. PubMed ID: 16343869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing in children.
    Holford N
    Clin Pharmacol Ther; 2010 Mar; 87(3):367-70. PubMed ID: 20090674
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric dose selection.
    Abernethy DR; Burckart GJ
    Clin Pharmacol Ther; 2010 Mar; 87(3):270-1. PubMed ID: 20160747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug development for children: how is pharma tackling an unmet need?
    Hawcutt DB; Smyth RL
    IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL; Wagner JA
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
    Chui J; Tordoff J; Reith D
    Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.